title: Could PD-L1 prove to be an effective therapeutic target for bladder cancer?
authors.affiliation: Yale Comprehensive Cancer Center, Yale School of Medicine, 333 Cedar Street, Fitkin 3, New Haven, CT 06520-8028, USA.
authors.forename: Navid
authors.initials: N
authors.lastname: Hafez
authors.forename: Daniel P
authors.initials: DP
authors.lastname: Petrylak
mesh_terms: D060890:B7-H1 Antigen / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D011173:Portraits as Topic; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000473:pathology* / Q000628:therapy*
chemical_list: D060890:B7-H1 Antigen; C423236:CD274 protein, human
keywords: immune checkpoint inhibition; urothelial bladder cancer